ClinicalTrialsFinder

Non-Syndromic Rod-Dominant Inherited Retinal Diseases Clinical Trials in Adelaide, South Australia

1 recruitingAdelaide, South Australia, Australia

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

Retinitis PigmentosaChoroideremiaNon-Syndromic Rod-Dominant Inherited Retinal Diseases
Kiora Pharmaceuticals, Inc.48 enrolled3 locationsNCT05282953